Clinical Trials Network announces first effort at Saint Thomas Ascension in Nashville

The Clinical Trials Network of Tennessee (CTN2) has announced plans to launch its inaugural clinical trial, the first in the network’s efforts to grow the clinical research volume at the University of Tennessee (UT) Health Science Center (UTHSC).

Since it was announced in April 2018, CTN2 has brought on eight clinical partners to establish the statewide network; launched an electronic data warehouse; partnered with TriNetX to bring in trial opportunities; and started promoting the network’s capabilities to pharmaceutical, biotech, and medical device companies. The inaugural trial will be conducted at Saint Thomas Ascension in Nashville and is recruiting patients to investigate ways to predict heart transplant rejection.

For more information about the subsidiary of the UT Research Foundation, read CTN2’s recent news release (CTN2 Release).

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.